Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of IDE849, IDE‑161 and durvalumab evaluating safety and efficacy in patients with DLL3‑positive tumors including small cell lung cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Spain
  • Safety and Tolerability of Inhaled KB707 with or without Docetaxel in Patients with Advanced Lung Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    France Spain
  • REGN10597 Alone or with Cemiplimab in Adults with Advanced Solid Tumours, Melanoma, or Clear-Cell Renal-Cell Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    France Germany Italy Spain
  • Safety and Preliminary Efficacy of Oral GSK5460025A Alone or with Drug Combination in Adult Patients with dMMR/MSI‑H Colorectal Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Italy The Netherlands Spain Sweden
  • A study to evaluate the safety and effectiveness of BMS-986523 alone or in combination with a drug combination for patients with advanced solid tumors and KRAS alterations.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Spain
  • A study to compare using a half dose of iomeprol versus a standard dose of iomeprol for imaging lung tumors with spectral CT scans.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • A study to investigate the safety and effectiveness of WEF-001 in patients with advanced KRAS-mutant solid tumors

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    Spain
  • Study of WEF-001 safety and effectiveness in patients with advanced KRAS-mutant solid tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study of Valemetostat Tosylate with Drug Combination for Patients with Previously Treated Solid Tumors

    Not yet recruiting

    1 1 1
    France Italy Spain
  • Study on Pembrolizumab, Atezolizumab, and Nivolumab with Carbon Ion Radiotherapy for Patients with Advanced Melanoma, Urothelial Carcinoma, NSCLC, or Head & Neck Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Italy